Incyte Corp (INCY)
52.81
+0.10
(+0.19%)
USD |
NASDAQ |
Apr 18, 16:00
52.81
0.00 (0.00%)
After-Hours: 20:00
Incyte Accounts Payable (Quarterly): 109.60M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 109.60M |
September 30, 2023 | 139.41M |
June 30, 2023 | 155.54M |
March 31, 2023 | 55.63M |
December 31, 2022 | 277.55M |
September 30, 2022 | 163.18M |
June 30, 2022 | 194.77M |
March 31, 2022 | 152.55M |
December 31, 2021 | 172.11M |
September 30, 2021 | 114.51M |
June 30, 2021 | 122.10M |
March 31, 2021 | 85.06M |
December 31, 2020 | 98.77M |
September 30, 2020 | 122.51M |
June 30, 2020 | 90.91M |
March 31, 2020 | 60.94M |
December 31, 2019 | 83.65M |
September 30, 2019 | 95.38M |
June 30, 2019 | 66.18M |
March 31, 2019 | 70.36M |
December 31, 2018 | 103.83M |
September 30, 2018 | 95.48M |
June 30, 2018 | 75.56M |
March 31, 2018 | 74.12M |
December 31, 2017 | 67.67M |
Date | Value |
---|---|
September 30, 2017 | 69.93M |
June 30, 2017 | 69.09M |
March 31, 2017 | 86.33M |
December 31, 2016 | 75.60M |
September 30, 2016 | 57.52M |
June 30, 2016 | 40.72M |
March 31, 2016 | 31.90M |
December 31, 2015 | 30.08M |
September 30, 2015 | 27.37M |
June 30, 2015 | 29.16M |
March 31, 2015 | 26.59M |
December 31, 2014 | 24.46M |
September 30, 2014 | 26.60M |
June 30, 2014 | 27.25M |
March 31, 2014 | 17.95M |
December 31, 2013 | 19.10M |
September 30, 2013 | 18.21M |
June 30, 2013 | 13.47M |
March 31, 2013 | 15.52M |
December 31, 2012 | 13.96M |
September 30, 2012 | 12.76M |
June 30, 2012 | 11.10M |
March 31, 2012 | 13.17M |
December 31, 2011 | 14.94M |
September 30, 2011 | 11.04M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
55.63M
Minimum
Mar 2023
277.55M
Maximum
Dec 2022
124.23M
Average
114.51M
Median
Sep 2021
Accounts Payable (Quarterly) Benchmarks
Novartis AG | 4.926B |
MorphoSys AG | 31.38M |
Illumina Inc | 245.00M |
Biogen Inc | 403.30M |
Exelixis Inc | 33.77M |